<unk>  is a Endocrine-Metabolic Agent that is FDA approved for the treatment of Fabry disease.   Common adverse reactions include infusion reactions.
Agalsidase beta
Glucarpidase
Pegaspargase
Laronidase
Glucuronosyltransferase
Alglucerase
Glycoprotein 2-beta-D-xylosyltransferase
Leader peptidase A